Across TCGA pan-cancer cohorts, ARHGAP42P1 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated ARHGAP42P1 data layer.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher ARHGAP42P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ARHGAP42P1 expression acts as an unfavorable survival marker, although some lineages such as BRCA and GBM show a favorable association.
COAD, UCS, and PAAD are the cancer types where ARHGAP42P1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.